1. A Phase I Study of Alpha‐1, 3‐Galactosyltransferase‐Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma. (6th September 2019) Authors: Hahn, Andrew W.; Drake, Charles; Denmeade, Samuel R.; Zakharia, Yousef; Maughan, Benjamin L.; Kennedy, Eugene; Link, Charles; Vahanian, Nicholas; Hammers, Hans; Agarwal, Neeraj Journal: Oncologist Issue: Volume 25:Number 2(2020) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers. Issue 9 (September 2022) Authors: Li, Haoran; Sahu, Kamal Kant; Kumar, Shruti Adidam; Nordblad, Blake; Sayegh, Nicolas; Tripathi, Nishita; Thomas, Vinay Mathew; Gupta, Sumati; Maughan, Benjamin L.; Agarwal, Neeraj; Swami, Umang Journal: Heliyon Issue: Volume 8:Issue 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study. Issue 33 (20th November 2021) Authors: Pal, Sumanta K.; McGregor, Bradley; Suárez, Cristina; Tsao, Che-Kai; Kelly, William; Vaishampayan, Ulka; Pagliaro, Lance; Maughan, Benjamin L.; Loriot, Yohann; Castellano, Daniel; Srinivas, Sandy; McKay, Rana R.; Dreicer, Robert; Hutson, Thomas; Dubey, Sarita; Werneke, Scott; Panneerselvam, Ashok... Journal: Journal of clinical oncology Issue: Volume 39:Issue 33(2021) Page Start: 3725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration‐Resistant Prostate Cancer: A Retrospective Study. Issue 1 (16th August 2016) Authors: Maughan, Benjamin L.; Luber, Brandon; Nadal, Rosa; Antonarakis, Emmanuel S. Journal: Prostate Issue: Volume 77:Issue 1(2017) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time. (2019) Authors: Hahn, Andrew W.; Stenehjem, David; Nussenzveig, Roberto; Carroll, Emma; Bailey, Erin; Batten, Julia; Maughan, Benjamin L.; Agarwal, Neeraj Journal: Cancer treatment and research communications Issue: Number 19(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform. (7th July 2021) Authors: Lin, Edwin; Hahn, Andrew W.; Nussenzveig, Roberto H.; Wesolowski, Sergiusz; Sayegh, Nicolas; Maughan, Benjamin L.; McFarland, Taylor; Rathi, Nityam; Sirohi, Deepika; Sonpavde, Guru; Swami, Umang; Kohli, Manish; Rich, Thereasa; Sartor, Oliver; Yandell, Mark; Agarwal, Neeraj Journal: Oncologist Issue: Volume 26:Number 9(2021) Page Start: 751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of Somatic Gene Signatures in Circulating Cell‐Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform. (7th July 2021) Authors: Lin, Edwin; Hahn, Andrew W.; Nussenzveig, Roberto H.; Wesolowski, Sergiusz; Sayegh, Nicolas; Maughan, Benjamin L.; McFarland, Taylor; Rathi, Nityam; Sirohi, Deepika; Sonpavde, Guru; Swami, Umang; Kohli, Manish; Rich, Thereasa; Sartor, Oliver; Yandell, Mark; Agarwal, Neeraj Journal: Oncologist Issue: Volume 26:Number 9(2021) Page Start: 751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High‐Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial. (1st November 2018) Authors: Maughan, Benjamin L.; Pal, Sumanta K.; Gill, David; Boucher, Kenneth; Martin, Christopher; Salgia, Meghan; Nussenzveig, Roberto; Liu, Ting; Hawks, Josiah L.; Batten, Julia; Nachaegari, Gayatri; Stephenson, Robert; Lowrance, William; Jones, Jeremy; Dechet, Christopher; Agarwal, Neeraj Journal: Oncologist Issue: Volume 23:Number 12(2018) Page Start: 1413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Neuroendocrine differentiation in usual‐type prostatic adenocarcinoma: Molecular characterization and clinical significance. Issue 12 (10th July 2020) Authors: Kaur, Harsimar; Samarska, Iryna; Lu, Jiayun; Faisal, Farzana; Maughan, Benjamin L.; Murali, Sanjana; Asrani, Kaushal; Alshalalfa, Mohamed; Antonarakis, Emmanuel S.; Epstein, Jonathan I.; Joshu, Corinne E.; Schaeffer, Edward M.; Mosquera, Juan Miguel; Lotan, Tamara L. Journal: Prostate Issue: Volume 80:Issue 12(2020) Page Start: 1012 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Olaparib and rucaparib for the treatment of DNA repair-deficient metastatic castration-resistant prostate cancer. (13th August 2021) Authors: Maughan, Benjamin L.; Antonarakis, Emmanuel S. Journal: Expert opinion on pharmacotherapy Issue: Volume 22:Number 12(2021) Page Start: 1625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗